Free Trial
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 2,700 +100.00 (+3.85%)
As of 11:47 AM Eastern

About Bioventix Stock (LON:BVXP)

Key Stats

Today's Range
2,600
2,700
50-Day Range
2,493
2,970
52-Week Range
2,200
4,550
Volume
1,989 shs
Average Volume
8,054 shs
Market Capitalization
£141.38 million
P/E Ratio
17.46
Dividend Yield
5.85%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

BVXP Stock News Headlines

Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
3 UK Dividend Stocks Offering Yields Up To 7.2%
3 top AIM stocks to consider buying before they recover
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 3,240 at the start of the year. Since then, BVXP shares have decreased by 16.7% and is now trading at GBX 2,700.
View the best growth stocks for 2025 here
.

Bioventix PLC (LON:BVXP) posted its earnings results on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share (EPS) for the quarter. Bioventix had a trailing twelve-month return on equity of 69.09% and a net margin of 59.51%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
3/31/2025
Record date for 4/25 Dividend
4/10/2025
Ex-Dividend for 4/25 Dividend
4/10/2025
Dividend Payable
4/25/2025
Today
6/23/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
LON:BVXP
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
17.46
Forward P/E Ratio
16.24
P/E Growth
N/A
Net Income
£8.12 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£13.65 million
Cash Flow
GBX 87.41 per share
Price / Cash Flow
30.89
Book Value
GBX 229.94 per share
Price / Book
11.74

Miscellaneous

Free Float
N/A
Market Cap
£141.38 million
Optionable
Not Optionable
Beta
0.35
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:BVXP) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners